Cantor Fitzgerald reiterates Rocket Lab stock rating on launch record

Cantor Fitzgerald reiterated an Overweight rating on Rocket Lab with an $85 price target, implying about 25% upside from the $68.05 share price. The company added a three-launch iQPS contract that lifts the total Electron missions for the customer to 15, reinforcing its launch backlog and execution record of more than 80 successful launches. Rocket Lab also reported $601.8 million in trailing 12-month revenue, up 38%, alongside 21 successful launches in fiscal 2025.

Analysis

RKLB is transitioning from a “story stock” to a more durable backlog-and-throughput compounder, but the market may still be underpricing how much of the near-term re-rating is already financed. The combination of repeated mission cadence and a large capital raise/forward structure reduces execution risk and extends runway, which matters because the stock is now trading more on confidence in multi-year launch cadence than on near-term earnings. The second-order effect is that every successful mission improves Rocket Lab’s credibility as a multi-launch provider, making it harder for smaller launch peers to win institutional customers on reliability alone.

The key nuance is that the valuation debate is no longer about whether demand exists; it is about whether Electron remains the right vehicle for value creation versus being a bridge to higher-margin systems and services. If management continues to use launch wins to cross-sell higher-value payload, spacecraft, and defense-adjacent work, the upside is in mix expansion rather than launch count. That creates a more defensible bull case than pure launch growth, but it also means any stumble in conversion from missions to services would compress the multiple quickly.

The main near-term risk is that the stock’s implied optimism can be fragile if the market shifts from “growth at any cost” to “show me margin leverage.” The financing removes one overhang, but it also invites skepticism that equity dilution is being used to fund growth before the business has fully earned it. In the next 3–6 months, the catalyst stack is less about launch headlines and more about whether management can show bookings, backlog quality, and gross margin stability that justify the current premium.

Key Decisions for Investors

• Stay long RKLB only on weakness, not strength: add on 5-8% pullbacks, targeting a 3-6 month hold if the stock de-risks into the mid-$60s; thesis is backlog durability and services mix expansion, not headline launch momentum.
• Buy RKLB call spreads for a 6-9 month horizon rather than outright stock: use a risk-defined structure to express upside while limiting downside if the market reprices dilution or valuation pressure; best if implied volatility remains elevated.
• Pair long RKLB / short a lower-quality aerospace-launch name or a basket of pre-profit growth hardware names over 3-6 months; the relative trade favors the company with proven cadence and financing runway if capital markets stay selective.
• Trim or avoid chasing after contract headlines unless management confirms margin or services conversion; the stock likely needs another operational beat to move higher, so upside from here is more execution-sensitive than sentiment-driven.
• Set a stop/review level if the stock loses the post-financing support zone on volume; a failure to hold there would signal that the market is treating the raise as dilution rather than strategic optionality.